Our Team

Our CEO, Mark Grosser, has been leading our team at 23Strands since its inception three years ago. Mark has over 25 years’ experience in the health technology industry working across Engineering, Management and R&D at firms such as Cochlear, Micromedical and the Henry Schein group. With a background in high technology engineering, healthcare data analysis and medical devices, he has been instrumental in leading the development of our cutting-edge whole genome sequencing data analysis and healthcare platforms that are now being used across IVF, CVD, and cancer. Under his leadership, the company has grown through the pandemic and is now one of the leading providers of genomic solutions for the healthcare industry in Australia.

Omer brings 20 years’ experience across technology leadership, project management, customer success, operations and senior management. With an advanced technology degree and over 20 years of experience in high performance computing and health data analytics, he has been instrumental in developing our cutting-edge platforms across patient management, data integration and multi-modal analysis.

As Director at 23Strands, Lisa Andrews continues to lead with vision and purpose, driving innovative solutions to some of the world’s most pressing challenges. Her career is rooted in a deep commitment to impactful leadership, previously serving as Co-CEO of Singularity University Australia, where she championed transformative ventures with global reach.

Lisa's journey is fueled by a mission to inspire and empower the next generation of innovators, with a bold ambition to positively impact over a billion lives. Her personal health experiences have sparked a passionate focus on women’s health, aligning closely with 23Strands’ mission to harness technology and innovation in tackling critical global health issues. Lisa brings a unique blend of strategic insight and heartfelt purpose to everything she does—advancing a future where health equity and innovation go hand in hand.

Steven is a recognised leader in health innovation and education. He was previously the Medical Director for eHealth NSW.

Murray is a Finance Professional, with over 30 years in financial markets, trading, financial structuring and risk management, treasury, compliance, operations and corporate governance.

An experienced professional with 25+ years in healthcare technology was previously the APAC Healthcare Director for Oracle Healthcare Global Business Unit. With executive roles in leading healthcare companies and developed education programs and frameworks for technological adoption models. With expertise in cloud adoption, precision medicine, and healthcare analytics, he's proactive and creative approach combined with a results-focused mindset brings valuable knowledge to 23Strands.

Prof Venter pioneered the use of many leading-edge genomic technologies in diagnostics. He has participated in the creation of a number of global healthcare technology companies and is widely published in the genomic literature.

Fab has been crucial to incorporating the 23Strands vision into the field of assisted reproductive technologies (ARTS.) He is an expert on ARTS focused on the development of new technologies to improve reproductive outcomes of couples suffering from infertility worldwide.

Dr Lin has been a leader in data science and has been applying these skills to real-world healthcare delivery. She was previously the head of data insights at MedicalDirector, Australia’s leading General Practice EMR software.

Overseeing the UX + UI team within 23Strands' development division, Robert brings a wealth of front-end development experience to the table. He's portfolio boasts collaborations with renowned brands like Alphapharm, Caesarstone, Samsung, and Abbott Australasia.

Leads 23Strands technical team across transactional and data insights solutions to deliver systems that integrate with business processes and have scope for ongoing growth